This is the company's third international buyout in the last 12 months. Last year in October, the company had acquired Pinewood, the largest generic firm in Ireland and the biggest supplier of liquid generic products in the UK. Wockhardt had also bought Negma, the fourth largest independent pharmaceutical firm in France in May.
Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations. The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.
A 22-year-old Indian-origin student has been reported missing from New York for nearly 10 days and the police is seeking the public's help to locate her.
The FDA had imposed a ban on the company's Waluj plant in May.
Authorities do not suspect any foul play was involved in Varughese's death but the cause of his death is yet to be ascertained, Chicago Sun-Times reported.
The family of a 19-year-old Indian-origin student, who was found dead in February under mysterious circumstances in the US, have alleged foul play and disputed the cause of his death given by the police.
Pravin M Varughese, 19, a student of Southern Illinois University, who had been missing for a week, was found dead on February 18.
Lovely Varughese, the mother of Pravin Varughese, 19, a student at the Southern Illinois University in Carbondale, Illinois, filed a civil suit against Gaege Bethune, 22, the last person to see Pravin alive, the City of Carbondale and Police Chief Jodi O'Guinn demanding compensation in excess of $1 million (Rs 10,00,000)from each.
From , May 15 (PTI) Four Indian Americans, including a physician and three co-owners of a health clinic from Chicago, have been charged with healthcare fraud estimated to be running into millions of dollars. Federal law enforcement officials said three Indian Americans Ankur Ro ...
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances